Up-and-comer Haim Zaltzman is held in high esteem by clients and peers alike, who describe him as "thoughtful and responsive" and "a top negotiator who knows the market well." His burgeoning finance practice is active on behalf of companies, lenders, and venture capital firms in a broad range of matters.

Chambers USA 2018

Haim Zaltzman

San Francisco | Silicon Valley
  • 505 Montgomery Street
  • Suite 2000
  • San Francisco, CA 94111-6538
  • USA
 
 

Haim Zaltzman focuses primarily on healthcare and technology-related private equity, growth equity, and emerging growth debt transactions. Mr. Zaltzman is the Chair of the Finance Department in Latham & Watkins' San Francisco and Silicon Valley offices.

Mr. Zaltzman frequently represents borrowers, sponsors, and financial institutions in debt financing transactions, including:

  • Over US$7 billion in growth debt (venture, structured, royalty, and lower middle market deals)         
  • Over US$6 billion in private equity and growth equity financings (acquisitions, add-ons, refinancings, etc.)    
  • Over US$1.5 billion in leasing and other similar transactions

Mr. Zaltzman holds leadership positions with the Chinese American International School, San Francisco State’s Guardian Scholars Program for emancipated foster youth, the Truman National Security Project, and the American Jewish Committee.

Mr. Zaltzman has also been featured on CNBC and Bloomberg and in The Washington Post, CFO Magazine, The Recorder, Law360.com, The Daily Journal, the International Financial Law Review, and VCExperts.com for his debt expertise. He was recognized as one of the Top 20 Under 40 lawyers in California by The Daily Journal in 2015.

Experience

 Mr. Zaltzman's representative transactions include:

  • Relypsa, Inc. in one of the largest structured debt financings of 2016 from leading healthcare debt providers
  • Hundreds of emerging growth companies in every type of debt financing, including over 30 structured healthcare and technology debt transactions in the past few years
  • The lending arm of top private equity firm in structured debt financings of late stage growth companies
  • A leading hedge fund in tens of structured debt transactions
  • A publicly traded business development company in tens of structured debt and venture debt transactions    
  • Various private equity sponsored portfolio companies in growth stage and lower middle market debt transactions provided by hedge funds and institutional investors 
  • Siga Technologies in a structured debt facility provided by a leading direct lender
  • Raptor Pharmaceuticals in a synthetic royalty and convertible note facility provided by a leading structured debt fund
  • Various venture capital firms in capital call lines, moving loans, and guaranty transactions
  • Various publicly traded technology companies in asset backed and syndicated loan transactions
Prior Professional Experience
  • Former Editor of the Stanford Journal of International Relations
  • Fulbright Scholar in Russia
  • Prior to Latham & Watkins, attorney in the New York office of Skadden, Arps, Slate, Meagher & Flom LLP
Thought Leadership
  • Emerging Growth Debt, Venture Capital General Counsel Meeting, Boulder, Colorado, March 29-30, 2017
  • Financing Emerging Growth Companies with Debt, Webcast, May 4, 2017
  • The Healthcare & Technology Industries’ Burgeoning Emerging Growth Debt Market, March 13, 2015
  • When Venture Funding is Debt, Not Equity, June 22, 2011
  • After the Credit Crunch: Venture Credit Facilities at the Term Sheet Stage, June 20, 2011
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.